Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 35 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.
Bain SC, Belmar N, Hoff ST, Husain M, Rasmussen S, Vilsbøll T, Petrie MC
Diabetes Ther, 09 Nov 2024
Cited by: 0 articles | PMID: 39520501
Add to export list
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.
Verma S, Colhoun HM, Dicker D, Hovingh GK, Kahn SE, Kautzky-Willer A, Lingvay I, Plutzky J, Rasmussen S, Rathor N, Hoff ST, Lincoff AM
J Am Coll Cardiol, 84(17):1678-1682, 30 Aug 2024
Cited by: 0 articles | PMID: 39217575
Add to export list
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.
Dahl K, Brooks A, Almazedi F, Hoff ST, Boschini C, Baekdal TA
Diabetes Obes Metab, 23(7):1594-1603, 29 Mar 2021
Cited by: 23 articles | PMID: 33710717 | PMCID: PMC8251575
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ex vivo mRNA expression of toll-like receptors during latent tuberculosis infection.
Alemnew B, Hoff ST, Abebe T, Abebe M, Aseffa A, Howe R, Wassie L
BMC Immunol, 22(1):9, 28 Jan 2021
Cited by: 3 articles | PMID: 33509080 | PMCID: PMC7842038
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.
Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M, Pedersen KB, Saugstrup T, Meier JJ, PIONEER 4 investigators
Lancet, 394(10192):39-50, 08 Jun 2019
Cited by: 178 articles | PMID: 31186120
Add to export list
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial.
Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, Tarp-Johansen MJ, Araki E, PIONEER 8 Investigators
Diabetes Care, 42(12):2262-2271, 17 Sep 2019
Cited by: 94 articles | PMID: 31530667 | PMCID: PMC7364672
Add to export list Free full text in Europe PMC
C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial.
Aggerbeck H, Ruhwald M, Hoff ST, Borregaard B, Hellstrom E, Malahleha M, Siebert M, Gani M, Seopela V, Diacon A, Lourens M, Andersen P, Dheda K
PLoS One, 13(9):e0204554, 24 Sep 2018
Cited by: 26 articles | PMID: 30248152 | PMCID: PMC6152999
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.
Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z, Tait D, Kromann I, Ruhwald M, Rutkowski KT, Shepherd B, Hokey D, Ginsberg AM, Hanekom WA, Hanekom WA, Andersen P, Scriba TJ, Hatherill M, H56-035 Trial Group
Am J Respir Crit Care Med, 199(2):220-231, 01 Jan 2019
Cited by: 55 articles | PMID: 30092143
Add to export list
Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.
Aggerbeck H, Ruhwald M, Hoff ST, Tingskov PN, Hellstrom E, Malahleha M, Siebert M, Gani M, Diacon A, Novelijc Z, Andersen P, Dheda K
Int J Tuberc Lung Dis, 23(1):38-44, 20 Dec 2018
Cited by: 6 articles | PMID: 30572979
Add to export list
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.
Hussein J, Zewdie M, Yamuah L, Bedru A, Abebe M, Dagnew AF, Chanyalew M, Yohannes AG, Ahmed J, Engers H, Doherty TM, Bang P, Kromann I, Hoff ST, Aseffa A
Trials, 19(1):24, 10 Jan 2018
Cited by: 16 articles | PMID: 29321075 | PMCID: PMC5764015
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.
Michelsen SW, Soborg B, Diaz LJ, Hoff ST, Agger EM, Koch A, Rosenkrands I, Wohlfahrt J, Melbye M
PLoS One, 12(6):e0177906, 01 Jun 2017
Cited by: 4 articles | PMID: 28570574 | PMCID: PMC5453477
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.
Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, Martinez JA, Kromann I, Penas A, Anibarro LL, de Souza-Galvão ML, Sánchez F, Rodrigo-Pendás JÁ, Noguera-Julian A, Martínez-Lacasa X, Tuñez MV, Fernández VL, Millet JP, Moreno A, [...] TESEC Working Group
Lancet Respir Med, 5(4):259-268, 01 Feb 2017
Cited by: 50 articles | PMID: 28159608
Add to export list
Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.
Moguche AO, Musvosvi M, Penn-Nicholson A, Plumlee CR, Mearns H, Geldenhuys H, Smit E, Abrahams D, Rozot V, Dintwe O, Hoff ST, Kromann I, Ruhwald M, Bang P, Larson RP, Shafiani S, Ma S, Sherman DR, Sette A, [...] Urdahl KB
Cell Host Microbe, 21(6):695-706.e5, 01 Jun 2017
Cited by: 109 articles | PMID: 28618268 | PMCID: PMC5533182
Add to export list Free full text in Europe PMC
Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.
Ruhwald M, de Thurah L, Kuchaka D, Zaher MR, Salman AM, Abdel-Ghaffar AR, Shoukry FA, Michelsen SW, Soborg B, Blauenfeldt T, Mpagama S, Hoff ST, Agger EM, Rosenkrands I, Aagard C, Kibiki G, El-Sheikh N, Andersen P
Sci Rep, 7:45969, 07 Apr 2017
Cited by: 20 articles | PMID: 28387329 | PMCID: PMC5384086
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.
Norrby M, Vesikari T, Lindqvist L, Maeurer M, Ahmed R, Mahdavifar S, Bennett S, McClain JB, Shepherd BM, Li D, Hokey DA, Kromann I, Hoff ST, Andersen P, de Visser AW, Joosten SA, Ottenhoff THM, Andersson J, Brighenti S
Vaccine, 35(12):1652-1661, 17 Feb 2017
Cited by: 28 articles | PMID: 28216183
Add to export list
H1:IC31 vaccination is safe and induces long-lived TNF-α⁺IL-2⁺CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.
Mearns H, Geldenhuys HD, Kagina BM, Musvosvi M, Little F, Ratangee F, Mahomed H, Hanekom WA, Hoff ST, Ruhwald M, Kromann I, Bang P, Hatherill M, Andersen P, Scriba TJ, THYB04 study group
Vaccine, 35(1):132-141, 18 Nov 2016
Cited by: 21 articles | PMID: 27866772
Add to export list
Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders.
Michelsen SW, Soborg B, Agger EM, Diaz LJ, Hoff ST, Koch A, Sorensen HCF, Andersen P, Wohlfahrt J, Melbye M
Vaccine, 34(48):5975-5983, 27 Oct 2016
Cited by: 3 articles | PMID: 27997344
Add to export list
Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
Zewdie M, Howe R, Hoff ST, Doherty TM, Getachew N, Tarekegne A, Tessema B, Yamuah L, Aseffa A, Abebe M
Tuberculosis (Edinb), 100:61-68, 09 Jul 2016
Cited by: 6 articles | PMID: 27553411 | PMCID: PMC5111553
Add to export list Free full text in Europe PMC
Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection.
Hoff ST, Peter JG, Theron G, Pascoe M, Tingskov PN, Aggerbeck H, Kolbus D, Ruhwald M, Andersen P, Dheda K
Eur Respir J, 47(3):919-928, 17 Dec 2015
Cited by: 36 articles | PMID: 26677940
Add to export list
Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells.
Lenz N, Schindler T, Kagina BM, Zhang JD, Lukindo T, Mpina M, Bang P, Kromann I, Hoff ST, Andersen P, Reither K, Churchyard GJ, Certa U, Daubenberger CA
Clin Vaccine Immunol, 22(7):688-696, 29 Apr 2015
Cited by: 8 articles | PMID: 25924764 | PMCID: PMC4478517
Add to export list Free full text in Europe PMC
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.
Luabeya AK, Kagina BM, Tameris MD, Geldenhuys H, Hoff ST, Shi Z, Kromann I, Hatherill M, Mahomed H, Hanekom WA, Andersen P, Scriba TJ, H56-032 Trial Study Group, Schoeman E, Krohn C, Day CL, Africa H, Makhethe L, Smit E, [...] Hussey GD
Vaccine, 33(33):4130-4140, 19 Jun 2015
Cited by: 112 articles | PMID: 26095509
Add to export list
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial.
Geldenhuys H, Mearns H, Miles DJ, Tameris M, Hokey D, Shi Z, Bennett S, Andersen P, Kromann I, Hoff ST, Hanekom WA, Mahomed H, Hatherill M, Scriba TJ, H4:IC31 Trial Study Group, van Rooyen M, Bruce McClain J, Ryall R, de Bruyn G, H4:IC31 Trial Study Groupa
Vaccine, 33(30):3592-3599, 03 Jun 2015
Cited by: 41 articles | PMID: 26048780
Add to export list
Author's response: BCG and infection with Mycobacterium tuberculosis.
Michelsen SW, Agger EM, Hoff ST, Soborg B, Carstensen L, Koch A, Lillebaek T, Sorensen HC, Wohlfahrt J, Melbye M
Thorax, 70(3):286-287, 17 Sep 2014
Cited by: 0 articles | PMID: 25232042
Add to export list
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial.
Reither K, Katsoulis L, Beattie T, Gardiner N, Lenz N, Said K, Mfinanga E, Pohl C, Fielding KL, Jeffery H, Kagina BM, Hughes EJ, Scriba TJ, Hanekom WA, Hoff ST, Bang P, Kromann I, Daubenberger C, Andersen P, Churchyard GJ
PLoS One, 9(12):e114602, 09 Dec 2014
Cited by: 39 articles | PMID: 25490675 | PMCID: PMC4260867
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells.
Hoff ST, Salman AM, Ruhwald M, Ravn P, Brock I, Elsheikh N, Andersen P, Agger EM
Tuberculosis (Edinb), 95(1):40-47, 22 Oct 2014
Cited by: 7 articles | PMID: 25476870
Add to export list

1-25 of 35 results

1 2

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Partnerships & funding